Eli Lilly teams up with Saudi hospital to advance Alzheimer’s care
Eli Lilly Saudi Arabia and King Faisal Specialist Hospital & Research Centre (KFSHRC) have teamed up to make KFSHRC’s Neuroscience…
Eli Lilly Saudi Arabia and King Faisal Specialist Hospital & Research Centre (KFSHRC) have teamed up to make KFSHRC’s Neuroscience…
Researchers at University College London (UCL) and University College London Hospitals (UCLH) in the UK have developed an AI-based tool…
ONWARD Medical has acquired an exclusive licence from CEA for the development and commercialisation of the WIMAGINE Brain-Computer Interface (BCI)…
PhotoPharmics has announced a pivotal development in its FDA "Light for PD" clinical trial of the Celeste therapeutic device, with…
A device currently in clinical trials for hydrocephalus could be used to deliver gene therapies to the central nervous system…
C2N Diagnostics has received an investment of up to $7.025m from the Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator for its…
The US Food and Drug Administration (FDA) has approved Neuros Medical’s electrical nerve stimulation system for the treatment of pain…
Stryker has already agreed to acquire multiple companies this year, and the medtech giant is showing no signs of slowing…
Inspire has achieved a significant milestone with the FDA approval of its Inspire V therapy system, an integral part of…
Orlando Health Orlando Regional Medical Center (ORMC) in the US has announced the use of Abbott’s i-STAT TBI blood test…